<?xml version="1.0" encoding="UTF-8" ?><rss 
        version         = "2.0"
        xmlns:content   = "http://purl.org/rss/1.0/modules/content/"
        xmlns:wfw       = "http://wellformedweb.org/CommentAPI/"
        xmlns:dc        = "http://purl.org/dc/elements/1.1/"
        xmlns:atom      = "http://www.w3.org/2005/Atom"
        xmlns:sy        = "http://purl.org/rss/1.0/modules/syndication/"
        xmlns:slash     = "http://purl.org/rss/1.0/modules/slash/"
        type            = "0"
                >
        <channel><item post_id='46099'><title>EpiVax gibt Lizenzierung eines COVID-19-Impfstoffkandidaten an EpiVax Therapeutics bekannt</title><link>https://business24.ch/2020/08/25/epivax-gibt-lizenzierung-eines-covid-19-impfstoffkandidaten-an-epivax-therapeutics-bekannt/</link><pubDate>Tue, 25 Aug 2020 20:00:02 +0000</pubDate>		<category><![CDATA[Presseportal]]></category>
		<category><![CDATA[Presseportal-Archiv]]></category>
		<category><![CDATA[noinjection]]></category>
<guid isPermalink='false'>https://business24.ch/?p=46099</guid><post-id xmlns="com-wordpress:feed-additions:1">46099</post-id></item></channel>
      </rss>